The outlook of companies tied to blockbuster drugs like Viagra presents a challenging investment landscape . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the loss of exclusivity in key regions has introduced significant risk . Investors are now grappling with the effect of generic